print   Print full article

What is it?

Insulin is a hormone produced by the beta cells in the pancreas. Small amounts of it are normally released after each meal to help transport glucose into the body’s cells, where it is needed for energy production. Insulin resistance is a decreased ability to respond to the effects of insulin, especially by muscle and adipose (fat) tissues. Since cells must have glucose to survive, the body compensates for insulin resistance by producing additional amounts of the hormone. This results in a state of hyperinsulinaemia in the blood and over-stimulation of some tissues that have remained insulin sensitive. Over time, this process causes an imbalance in the relationship between glucose and insulin and can cause an unhealthy ripple effect in the body.

Hyperinsulinaemia and insulin resistance can affect the proportion of the body’s lipids, significantly increasing the amount of triglycerides and sdLDLs (small dense lipoproteins) in the blood and decreasing the amount of HDL (high density lipoprotein, the “good cholesterol”). It may also increase a person’s risk of developing a blood clot, cause inflammatory changes, and increase a person’s sodium retention, which can lead to increased blood pressure. Approximately 50% of people with essential hypertension have insulin resistance.

Insulin resistance is not a disease or specific diagnosis, but it has been associated with conditions such as cardiovascular disease (CVD), hypertension, polycystic ovarian syndrome, type 2 diabetes, obesity, and nonalcoholic fatty liver disease. Some researchers also believe that there may be a link between insulin resistance and some forms of cancer. The mechanisms of these associations, however, are not well understood. It is important to remember that many of the people who have these conditions do not have insulin resistance and, likewise, many of the people who have insulin resistance will never develop these conditions. These are just patterns of association that have emerged. They are frequently seen together and it is thought that insulin resistance may contribute to their development and exacerbate them when it is present.

Metabolic syndrome and insulin resistance syndrome are two terms that have been used to characterise some of the abnormalities associated with insulin resistance and to recognise them as risk factors for future disease. Although both terms are often used interchangeably, metabolic syndrome is more of a subset of the insulin resistance syndrome. It is a worldwide effort to identify patients who are primarily obese and sedentary and who are beginning to experience alterations in lipid levels and impaired glucose processing. The focus is on educating them about their increased risk of developing CVD and/or type 2 diabetes and on working with them to lower that risk through lifestyle changes. Since obesity and lack of exercise are known to exacerbate insulin resistance and exercise is known to increases the body’s sensitivity to insulin, identifying and treating those with metabolic syndrome also improves their insulin resistance. The insulin resistance syndrome term is broader. Its intent is to define and catalogue the abnormalities and conditions that have been associated with insulin resistance and hyperinsulinaemia (the body’s ripple effect).

The cause of insulin resistance is not fully understood. It is thought to be due partly to genetic factors, including ethnicity, and partly to lifestyle, such as excessive food intake and inadequate exercise. Most patients with insulin resistance do not have any symptoms – they do not realise that this process is taking place in their bodies. In most cases, the body is able to keep pace with the need for extra insulin production, and the effects of it on the body are subtle and years in the making. If or when the body’s insulin production fails to keep up with demand, then hyperglycaemia will occur. Over time, hyperglycaemia can progress and become type 2 diabetes, which can damage body organs.


Last Review Date: October 25, 2018